Gland Pharma Appoints Prasadha Rao Lysetti as Sr. Vice-President (Head - Operations)
Gland Pharma Limited announced the appointment of Mr. Prasadha Rao Lysetti as Senior Vice-President (Head - Operations), effective April 06, 2026. This move designates Mr. Lysetti as a Senior Management Personnel of the Company.The company released details regarding the appointment, providing a profile of Mr. Lysetti and outlining the details as required concerning the change in senior management.
| Particulars | Details |
|---|---|
| Reason for change | Mr. Prasadha Rao Lysetti has been appointed as Sr. Vice-President (Head - Operations), a Senior Management Personnel of the Company with effect from April 06, 2026. |
| Date of Change | April 06, 2026 |
Mr. Prasadha Rao Lysetti brings extensive experience to the role, described as a senior operations executive with over 25 years of progressive expertise in managing complex formulations and large-scale pharmaceutical manufacturing. His background includes solid experience across diverse cultures and global locations.
His professional track record highlights a strong capability in driving Quality-centric operations, enhancing Operational Efficiency, and leading Lean and Operational Excellence initiatives. Prior to joining Gland Pharma, Mr. Lysetti was associated with several firms, including Cronus Pharma India Private Limited (Rising Pharmaceuticals Group), Vitema Pharmaceuticals, Eugia Pharma Specialities Limited, Dr. Reddy's Laboratories Limited, Glenmark Generics Ltd, and Pharma Care FZE LLC.
Academically, Mr. Prasadha Rao holds a Post-Graduate degree in Chemistry and completed the Senior Management Programme in General Business Management from IIM - Calcutta. Furthermore, he possesses a Certified Six Sigma Black Belt from the American Society for Quality.
Gland Pharma Limited's corporate details indicate that the company is listed with the following identifiers:
- Symbol: GLAND
- ISIN: INE068V01023
- Scrip Code: 543245
GLAND Stock Price Movement
In today's trade, Gland Pharma Limited shares are currently trading at ₹1707.90, having moved between ₹1665.40 and ₹1736.00. The stock is showing moderate activity, trading up 1.14% in the market.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.